RxSight, Inc. (RXST) stock
RXSTNasdaqOphthalmic GoodsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 10/3076% below fair value
$4.83−0.47 (-8.87%)
Close on Nov 17, 2026Market cap $200.90MP/E –Yield –
RxSight pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
RxSight's pe ratio was 1.3× on Oct 29, 2021.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2021 | Oct 29, 2021 | 1.3× | – |
See a number that looks wrong?